Scout | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

This grant opportunity aims to fund collaborative research projects that study the long-term side effects of cancer treatments, which can become chronic health issues or appear later after treatment. It supports basic, translational, and clinical research to uncover the mechanisms behind these side effects, describe them clinically, and develop ways to prevent or lessen them. The research shou…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: September 22, 2021

Open for Submission: September 22, 2021

Submission Deadline: November 5, 2024

Application Window Closes: November 5, 2024

Keywords

cancer therapy

adverse sequelae

clinical trials

translational research

chronic comorbidities

mechanistic studies

therapeutic approaches

clinical endpoints

biomarkers

patient-reported outcomes

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers